IDEXX (IDXX) EVP Erickson gets amended 2026 stock option awards

Rhea-AI Filing Summary

IDEXX Laboratories Executive Vice President Michael G. Erickson reported corrected equity awards and updated holdings. The amended filing states that on February 12, 2026 he received a non‑qualified stock option for 13,667 shares and an incentive stock option for 162 shares, both with an exercise price equal to that day’s closing stock price.

The non‑qualified option vests in four annual installments beginning February 14, 2027, while the incentive stock option becomes exercisable in a single installment on February 14, 2030. The amendment clarifies that previously reported grants of 6,319 restricted stock units did not occur, and notes his common stock holdings include 184 vested but deferred restricted stock units.

Insights

Equity Compensation Analyst

Routine option grants and a clerical correction, with no economic change.

The filing shows IDEXX Laboratories Executive Vice President Michael G. Erickson received option awards on February 12, 2026: a non‑qualified option for 13,667 shares and an incentive stock option for 162 shares, both priced at that day’s closing share price.

The amendment explains that an earlier report mistakenly showed 6,319 restricted stock units granted on that date, which did not occur. Instead, only the two option grants are in effect, with vesting over four years for the larger grant and a single exercise date in 2030. Overall, this appears to be standard executive compensation reporting rather than a thesis‑changing event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Erickson Michael G

(Last) (First) (Middle)

ONE IDEXX DRIVE

(Street)

WESTBROOK ME 04092

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
02/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								15,092.351(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy)(2)	$617.2	02/12/2026		A		13,667		(3)	02/11/2036	Common Stock	13,667	$0	13,667	D
Incentive Stock Option (right-to-buy)(2)	$617.2	02/12/2026		A		162		(4)	02/11/2036	Common Stock	162	$0	162	D

Explanation of Responses:

1. Includes 184 vested but deferred restricted stock units.

2. This Amendment on Form 4/A (this 'Amendment') amends the Form 4 filed on February 17, 2026 (the 'Original Form 4') solely to correct an administrative error, which resulted in the inadvertent erroneous reporting of the equity awards granted to the reporting person on February 12, 2026. Specifically, Table II of the Original Form 4 incorrectly reported that 6,319 restricted stock units (of which 1,580 restricted stock units were deferred) were granted to the reporting person on February 12, 2026, which did not occur. Instead, as reported in this Amendment, a non-qualified stock option to purchase 13,667 shares of Issuer common stock and an incentive stock option to purchase 162 shares of Issuer common stock were granted to the reporting person on February 12, 2026, with an exercise price equal to the closing price of the Issuer's common stock on that day. This Amendment does make any other changes to the Original Form 4.

3. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.

4. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.

Remarks:

	/s/ Lily J. Lu, Attorney-in-Fact for Michael G. Erickson	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did IDEXX (IDXX) disclose for Michael G. Erickson on February 12, 2026?

IDEXX reported that Michael G. Erickson received two option grants on February 12, 2026: a non-qualified stock option for 13,667 shares and an incentive stock option for 162 shares, both with an exercise price equal to IDEXX’s closing stock price that day.

Why did IDEXX (IDXX) file an amended Form 4/A for Michael G. Erickson?

The amendment corrects an administrative error in a prior Form 4 that had wrongly reported a grant of 6,319 restricted stock units. The company clarifies these restricted stock units were not granted, and that Erickson instead received the two option awards disclosed in the amended filing.

How do Michael G. Erickson’s new stock options at IDEXX (IDXX) vest?

The non-qualified stock option for 13,667 IDEXX shares vests in four annual installments beginning February 14, 2027. The 162-share incentive stock option becomes exercisable in a single installment on February 14, 2030, reflecting longer-term incentive alignment for the executive.

What exercise price applies to Michael G. Erickson’s new IDEXX (IDXX) option grants?

Both the 13,667-share non-qualified option and the 162-share incentive stock option have an exercise price equal to the closing price of IDEXX common stock on February 12, 2026. This ties the grants’ value directly to that day’s market price at issuance.

Did IDEXX (IDXX) report any restricted stock units for Michael G. Erickson in this amendment?

The amendment clarifies that a previously reported grant of 6,319 restricted stock units did not occur. It notes that Erickson’s common stock holdings include 184 vested but deferred restricted stock units, which are part of his existing equity position, not new awards.

What is Michael G. Erickson’s reported common stock position in IDEXX (IDXX) after these transactions?

Following the reported transactions, Erickson holds 15,092.351 shares of IDEXX common stock directly. This figure includes 184 vested but deferred restricted stock units, reflecting both standard share ownership and deferred equity components in his overall position.